May 5th, 2021 – Cellares secures $82M Series B To Address Cell Therapy Manufacturing Obstacles
May 05, 2021
Crunchbase
Related News
-
November 12, 2024Cellares Appoints Ossama Eissa, Former Novartis, Lonza, and Legend Biopharma Leader as Chief Operating Officer
-
September 12, 2024
Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform
-
September 05, 2024
Cellares Announces Completion of First cGMP Cell Shuttle at IDMO Smart Factory in Bridgewater, New Jersey
